Clincosm LogoSign in Get a demo

esophageal neoplasms

Showing 26 - 50 of 149
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Esophageal Tumors Trial in Houston

Completed
  • Esophageal Neoplasms
    • Houston, Texas
      Baylor College of Medicine
    Jul 19, 2022

    Esophageal Tumors Trial in Dresden (Povidone-Iodine)

    Completed
    • Esophageal Neoplasms
    • Dresden, Germany
      Department of GI, Thoracic and Vascular Surgery, University Hosp
    Jul 13, 2022

    Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

    Recruiting
    • Esophagogastric Tumors
    • +9 more
    • Basking Ridge, New Jersey
    • +6 more
    Jul 8, 2022

    Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced

    Recruiting
    • Esophageal Neoplasms
    • an anti-PD-1/PD-L1 antibody plus an angiogenesis inhibitor
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Apr 21, 2022

    Esophageal Tumors Trial (Apatinib, The chemotherapeutic drug chosen by the investigator.)

    Withdrawn
    • Esophageal Neoplasms
    • Apatinib
    • The chemotherapeutic drug chosen by the investigator.
    • (no location specified)
    Apr 11, 2022

    Esophageal Tumors, Lung Tumors, Mesothelioma Trial run by the NCI (Mithramycin)

    Terminated
    Has Results
    • Esophageal Neoplasms
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Mar 10, 2022

    TreatmENT of AnastomotiC Leakage After Esophagectomy

    Completed
    • Esophageal Cancer
    • Esophageal Neoplasms
    • Intervantions for anastomotic leakage after esophagectomy
    • Nijmegen, Netherlands
      Radboudumc surgical department
    Mar 31, 2022

    Anlotinib Retrospective Study for Esophageal Cancer

    Completed
    • Esophageal Neoplasms
    • Zhengzhou, Henan, China
      The First Affiliated Hospital of Zhengzhou University
    Mar 27, 2022

    Esophageal Squamous Cell Carcinoma, Esophageal Tumors, Esophageal Diseases Trial (Anlotinib HCl, TQB2450)

    Not yet recruiting
    • Esophageal Squamous Cell Carcinoma
    • +10 more
    • (no location specified)
    Feb 19, 2022

    Esophageal Fistula, Esophageal Tumors, Esophageal Perforation Trial in United States (Evolution® Esophageal Stent - Fully

    Completed
    Has Results
    • Esophageal Fistula
    • +4 more
    • Evolution® Esophageal Stent - Fully Covered
    • Phoenix, Arizona
    • +10 more
    Jan 31, 2022

    Gastric Tumor, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Dresden, Heidelberg (Biopsy)

    Active, not recruiting
    • Gastric Neoplasm
    • +4 more
    • Biopsy
    • Dresden, Germany
    • +1 more
    Feb 22, 2022

    Colorectal Tumors, Stomach Tumor, Esophageal Tumors Trial in Cork, Dublin 8 (Lithium, Oxaliplatin, Capecitabine)

    Recruiting
    • Colorectal Neoplasms
    • +2 more
    • Cork, Ireland
    • +1 more
    Feb 9, 2022

    Barrett's Esophagus and Early Esophageal Cancer

    Terminated
    • Barrett Esophagus
    • +4 more
    • CSA System (CryoSpray AblationTM System)
    • CryoSpray Ablation
    • Baltimore, Maryland
      University of Maryland School of Medicine and Greenebaum Cancer
    Jan 25, 2022

    Esophageal Cancer After Definitive Radiotherapy in China

    Completed
    • Esophageal Neoplasms
    • definitive radiotherapy or definitive chemoradiotherapy
    • Beijing, China
      Department of Radiation Oncology, National Cancer Center/Nationa
    Jan 14, 2022

    Esophageal Tumors, Stomach Tumor, Colonic Tumors Trial in Rozzano, Castelfranco Veneto (Promotion of competences of participant

    Completed
    • Esophageal Neoplasms
    • +2 more
    • Promotion of competences of participant involved in the management of the post operative period
    • Rozzano, Milan, Italy
    • +1 more
    Jan 13, 2022

    Esophageal Tumors Trial in Shantou (SMART, PF)

    Completed
    • Esophageal Neoplasms
    • Shantou, Guangdong, China
      Cancer Hospital, Shantou University Medical College
    Dec 27, 2021

    Esophageal Tumors, Esophageal Squamous Cell Carcinoma Trial in China (PD-1 inhibitor, Albumin-Bound Paclitaxel, Cisplatin)

    Recruiting
    • Esophageal Neoplasms
    • Esophageal Squamous Cell Carcinoma
    • PD-1 inhibitor
    • +3 more
    • Fuzhou, Fujian, China
    • +5 more
    Dec 5, 2021

    Esophageal Tumors, Esophageal Cancer, Cancer of the Esophagus Trial in Saint Louis (drug, radiation, procedure)

    Completed
    • Esophageal Neoplasms
    • +2 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 23, 2021

    Stomach Tumor, Gastrointestinal Tumors, Digestive System Tumor Trial in Havana (Ocoxin-Viusid®)

    Recruiting
    • Stomach Neoplasm
    • +9 more
    • Ocoxin-Viusid®
    • Havana, La Habana, Cuba
      National Institute of Oncology and Radiobiology (INOR)
    Oct 20, 2021

    Esophageal Tumors, Thrombosis, Thromboembolism Trial in Aarhus N (Fragmin 5000 UNT in 0.2 ML Prefilled Syringe)

    Recruiting
    • Esophageal Neoplasms
    • +2 more
    • Fragmin 5000 UNT in 0.2 ML Prefilled Syringe
    • Aarhus N, Denmark
      Thrombosis and Haemostasis Research Unit, Department for Clinica
    Sep 23, 2021

    Mayo Clinic Upper Digestive Disease Survey

    Recruiting
    • Esophageal Neoplasms
    • +6 more
    • Mayo Clinic Conduit Report Card Questionnaires
    • Rochester, Minnesota
      Mayo Clinic
    Sep 14, 2021

    Metastatic Pancreatic Cancer, Colorectal Cancer, Esophageal Tumors Trial in Japan, United States (TAK-931)

    Completed
    Has Results
    • Metastatic Pancreatic Cancer
    • +3 more
    • Denver, Colorado
    • +9 more
    Aug 24, 2021

    Esophageal Tumors, Adenocarcinoma of the Gastroesophageal Junction, Gastroesophageal Cancer Trial in United States (DKN-01,

    Completed
    • Esophageal Neoplasms
    • +4 more
    • Los Angeles, California
    • +9 more
    Sep 9, 2021

    Esophageal Tumors Trial in Guangzhou (Irreversible electroporation (IRE), NanoKnife)

    Completed
    • Esophageal Neoplasms
    • Irreversible electroporation (IRE)
    • NanoKnife
    • Guangzhou, Guangdong, China
      Biological treatment center in Fuda cancer hospital
    Sep 1, 2021

    Sub-epithelial Lesions Among Patients Undergoing EGDs in Egypt

    Unknown status
    • Esophageal Neoplasms
    • +2 more
    • Endoscopic ultrasound
    • Kafr Ash Shaykh, Kafrelsheikh, Egypt
      Kafrelsheikh University
    Aug 30, 2021